BofA/Merrill Lynch Downgrades HEALTHSOUTH (HLS) to Underperform
Tweet
Share
E-mailGet Alerts HLS Hot Sheet
Price: $49.41 --0%
Rating Summary:
8 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA/Merrill Lynch downgraded HEALTHSOUTH (NYSE: HLS) from Neutral to Underperform.
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $17.67 yesterday.
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $17.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
- Avery Dennison (AVY) PT Raised to $212 at BofA Securities
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
